Yan Tan

Dr. Yan Tan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in The FASEB Journal
Verified
Journal Article
Open access
YDYunxiao Dou
Yunxiao Dou
YTYan Tan
Yan Tan
Amyloid‐β (Aβ) peptide is accumulated in the mitochondria and has been shown to play a central role in the development of Alzheimer's disease (AD). It has been shown that exposure of neurons to aggregated Aβ can result in damaged mitochondria and dysregulated mitophagy, indicating that changes in the Aβ content of mitochondria may affect the levels of mitophagy and interfere with the progression of AD. However, the direct influence of mitochondrial Aβ on mitophagy has not been elucidated. In the present study, the effect of the mitochondria‐specific Aβ was assessed following a direct change of Aβ content in the mitochondria. We directly change mitochondrial Aβ by transfecting cells with mitochondria‐associated plasmids, including the mitochondrial outer membrane protein translocase 22 (TOMM22) and 40 (TOMM40) or presequence protease (PreP) overexpression plasmids. The changes in the levels of mitophagy were assessed by TEM, Western blot, mito‐Keima construct, organelle tracker, and probe JC‐1 assay. We demonstrated that increased mitochondrial Aβ content enhance mitophagy levels; overexpression of PreP could reverse the mitochondrial Aβ‐induced mitophagy levels in vivo and in vitro by reversing the levels of reactive oxygen species (ROS) and the mitochondrial membrane potential. The data provide novel insight into the role of mitochondria‐specific Aβ in the progression of AD pathophysiology.

15 October 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YDYunxiao Dou
Yunxiao Dou
JXJunchao Xie
Junchao Xie
YTYan Tan
Yan Tan
MZMin Zhang
Min Zhang
YZYan-Xin Zhao
Yan-Xin Zhao
XLXueyuan Liu
Xueyuan Liu
The ratio of excitatory to inhibitory neurotransmitters is essential for maintaining the firing patterns of neural networks, and is strictly regulated within individual neurons and brain regions. Excitatory to inhibitory (E/I) imbalance has been shown to participate in the progression of neurodegenerative diseases, including Alzheimer's disease (AD). Glutamate excitotoxicity and GABAergic neuron dysfunction appear to be key components of the neuronal cell death that takes place in AD. Since extracellular vesicles (EVs) are now explored as an important vehicle in transmitting signals between cells, we hypothesized that the function of neuron-derived small EVs (sEVs) might be regulated by the status of neurotransmitter balance and that sEVs might affect amyloid β (Aβ) toxicity on neurons. This study aimed to reveal the effects of sEVs from unbalanced neurotransmitter-stimulated neurons on Aβ-induced toxicity. We demonstrated the opposite effects of the two groups of sEVs isolated from neurons stimulated by glutamate or GABA on Aβ toxicity in vivo and in vitro. The sEVs released from GABA-treated neurons alleviated Aβ-induced damage, while those released from glutamate-treated neurons aggravated Aβ toxicity. Furthermore, we compared the microRNA (miRNA) composition of sEVs isolated from glutamate/GABA/PBS-treated neurons. Our results showed that glutamate and GABA oppositely regulated miR-132 levels in sEVs, resulting in the opposite destiny of recipient cells challenged with Aβ. Our results indicated that manipulating the function of sEVs by different neurotransmitters may reveal the mechanisms underlying the pathogenesis of AD and provide a promising strategy for AD treatment.

1 July 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
XTXiangzhu Tian
Xiangzhu Tian
LGLi Gong
Li Gong
AJAiping Jin
Aiping Jin
YWYu Wang
Yu Wang
XZXiaoyu Zhou
Xiaoyu Zhou
YTYan Tan
Yan Tan
Elevated plasma homocysteine (Hcy), known as hyperhomocysteinemia (HHcy), is an independent risk factor for neurodegenerative diseases. Hcy, even at a low concentration, can promote free radical formation and increase oxidative stress, leading to neuronal death, which may be an important mechanism underlying the pathogenesis of neurodegenerative diseases. Although several reports have indicated that the nuclear translocation of glyceraldehyde 3‑phosphate dehydrogenase (GAPDH) may be involved in Hcy‑induced apoptosis, the exact mechanism remains to be fully elucidated. The siah E3 ubiquitin protein ligase 1 (siah‑1) gene was found to be critical for the translocation of GAPDH from the cytoplasm to the nucleus. In the present study, the role of siah‑1 was investigated in the nuclear translocation of GAPDH in rat C6 astroglioma cells treated with Hcy. C6 cells were treated with various concentrations of Hcy for 48 h and the expression level of siah‑1 was examined using reverse transcription‑quantitative polymerase chain reaction and western blotting analysis. In addition, the subcellular localization of siah‑1 and GAPDH and the interaction between these two factors were investigated by immunofluorescence staining and co‑immunoprecipitation assay, respectively. The results showed that Hcy at a high concentration increased the expression of siah‑1 and induced nuclear translocation of siah‑1 and GAPDH. In addition, siah‑1 knockdown by siah‑1 small interfering RNA significantly decreased the Hcy‑induced nuclear accumulation of GAPDH and inhibited the impairment of C6 cells. These findings suggest that siah‑1 is involved in Hcy‑induced cell damage by promoting the nuclear translocation of GAPDH.

15 March 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
YTYan Tan
Yan Tan
YGYongzhe Gu
Yongzhe Gu
YZYichen Zhao
Yichen Zhao
YLYou Lu
You Lu
XLXueyuan Liu
Xueyuan Liu
YZYan-Xin Zhao
Yan-Xin Zhao

24 July 2025 in Archives of Rehabilitation Research and Clinical Translation
Verified
Journal Article
Open access
YDYunxiao Dou
Yunxiao Dou
SQSiyu Qian
Siyu Qian
YZYichen Zhao
Yichen Zhao
YTYan Tan
Yan Tan
YZYan-Xin Zhao
Yan-Xin Zhao
To investigate the clinical effects of olfactory training (OT) on olfactory function and related nonmotor symptoms in patients with Parkinson disease (PD). Randomized controlled trial with a duration of 6 months of follow-up. A tertiary hospital providing neurology rehabilitation services in China. Of 81 initially recruited PD patients, 70 completed the study (N=70, 35 per group after randomization: OT group n=35, control n=35). All participants met inclusion criteria and received standard medical care. No dropouts were because of adverse effects. The intervention group received OT using a standardized protocol. The training involved daily exposure to specific odorants for 6 months. The control group did not receive OT. Primary outcomes included changes in olfactory test scores, memory and cognition scores (assessed using neuropsychological tests), and depressive and anxiety scale scores. These were measured before and after the 6-month intervention. After 6 months, the intervention group exhibited significant improvements in olfactory test scores (threshold-discrimination-identification score: t=3.839, P<.01, Cohen’s d=0.649), memory (memory quotient: t=2.597, P<.05, Cohen’s d=0.439) and cognition scores (Mini-Mental State Examination: z=−2.791, P<.01, rank-biserial correlation (r)=−0.330 and Montreal Cognitive Assessment: t=2.626, P<.05, Cohen’s d=0.444), depressive (Hamilton Depression Scale: z=−3.601, P<.001, r=−0.425 and Patient Health Questionnaire-9: z=−2.396, P<.05, r=−0.29) and anxiety (Hamilton Anxiety Scale: z=−3.049, P<.01, r=−0.36 and Generalized Anxiety Disorder-7: z=−2.849, P<.01, r=0.336) scale scores compared to the control group, showing moderate effects, respectively. The increase in memory scale scores was positively correlated with the increase in olfactory scores (Spearman r=0.415, P<.05). Statistical analysis was performed using SPSS 27.0 software, with P values indicating significance. The OT has beneficial effects on olfactory function and related nonmotor symptoms in patients with PD. The 6-month training led to significant improvements in memory, cognition, depression, and anxiety. Further studies are needed to determine the long-term effects and optimal duration of OT for patients with PD.

2 January 2019 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
YLYou Lu
You Lu
JYJia Yu
Jia Yu
JHJian Hu
Jian Hu
YTYan Tan
Yan Tan
JWJiayan Wu
Jiayan Wu
XLXueyuan Liu
Xueyuan Liu
BACKGROUND:Effective early management of cerebral infarction patients with transient ischemic attack (TIA) is undermined by an inability to predict who is at highest risk of stroke. MATERIAL AND METHODS:A total of 577 TIA patients with symptoms lasti...